Timing of Breakthrough Infection Risk After Vaccination Against SARS-CoV-2

Ashleigh Tuite; Nelson Lee; David Fisman.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-22268773

Documentos relacionados

  1. Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.
  2. Adverse Events Following Immunization With mRNA and Viral Vector Vaccines in Individuals With Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection From the Canadian National Vaccine Safety Network.
  3. Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
  4. Determinants of SARS-CoV-2 IgG response and decay in Canadian healthcare workers: A prospective cohort study.
  5. Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2.
  6. Riding high: seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020-February 2022.
  7. Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice.
  8. Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada.
  9. A comprehensive, open-source data model for wastewater-based epidemiology.
  10. Low antibody levels associated with significantly increased rate of SARS-CoV-2 infection in a highly vaccinated population from the US National Basketball Association.